BrightGene Bio-Medical Technology is a leading biopharmaceutical company in China, specializing in the research, development, and production of high-quality APIs (Active Pharmaceutical Ingredients) and advanced intermediates. The company is dedicated to innovation in the fields of oncology, diabetes, and antiviral therapies, offering a broad portfolio of products that meet international standards. With a strong focus on R&D and state-of-the-art manufacturing facilities, BrightGene serves clients worldwide, ensuring compliance with stringent regulatory requirements.